Microvascular Dysfunction Associates With Outcomes in Hypertrophic Cardiomyopathy: Insights From the Intravoxel Incoherent MotionMRI
Authors:
- 6 October 2022
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 57 (6) , 1766-1775
Abstract
Background Although intravoxel incoherent motion (IVIM) MRI has emerged as an in vivo marker of tissue diffusion and perfusion, its prognostic value in patients with hypertrophic cardiomyopathy (HCM) remains unclear. Purpose To investigate whether IVIM-MRI derived parameters are associated with outcomes in patients with HCM. Study Type Prospective cohort. Subjects A total of 112 patients (51.72 +/- 17.13 years) with suspected or known HCM. Field Strength/Sequence Single-shot echo planar IVIM imaging, balanced steady-state free precession, and phase-sensitive inversion-recovery late gadolinium enhancement (LGE) sequences at 3 T. Assessment All patients were followed up of 29.3 +/- 12.3 months for combined major adverse cardiac events (MACE) including cardiac death, aborted sudden death, heart transplantation, and rehospitalization for heart failure. The CVI42 imaging platform was used to assess morphological and functional MRI indices and to quantify LGE. The Body Diffusion Toolbox was used to derive pseudo diffusion (D*), water molecular diffusion (D) and perfusion fraction (f). Statistical Tests Univariable and stepwise multivariable Cox model analyses were used to investigate the association between variables and composite endpoints. Kaplan-Meier curves were constructed to assess event-free survival, and the event rates were compared by the log-rank test. Results A total of 19 patients reached endpoints. Patients with MACE showed a significantly impaired D* value, lower f value, and more extensive LGE than those without MACE (all, P < 0.05), while there was no significant difference in D value (P = 0.285). In the Cox regression models, D* value (hazard ratio [HR] 0.93; 95% CI: 0.88-0.98) and f value (HR 0.65; 95% CI: 0.45-0.92) were independent predictors for MACE. Moreover, in Kaplan-Meier survival analysis, the incidence of MACE was significantly higher in patients with decreased D* value and f value. Conclusions Impaired D* and f values derived from IVIM-MRI are associated with adverse outcomes in patients with HCM. Level of Evidence 2 Technical Efficacy Stage 2Keywords
Funding Information
- National Key Research and Development Program of China (2021YFF0501400, 2021YFF0501404)
This publication has 28 references indexed in Scilit:
- Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancementJournal of Cardiovascular Magnetic Resonance, 2016
- Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and FutureRadiology, 2016
- Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistanceCardiovascular Revascularization Medicine, 2015
- Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculationEuropean Heart Journal, 2015
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic CardiomyopathyCirculation, 2014
- Coronary microvascular dysfunction: an updateEuropean Heart Journal, 2013
- In Vivo Cardiac Diffusion-Weighted Magnetic Resonance ImagingInvestigative Radiology, 2012
- In vivo study of microcirculation in canine myocardium using the IVIM method†Magnetic Resonance in Medicine, 2003
- MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.Radiology, 1986